PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+9.36%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$5B
AUM Growth
+$5B
(-9.3%)
Cap. Flow
-$573M
Cap. Flow
% of AUM
-11.45%
Top 10 Holdings %
Top 10 Hldgs %
42.58%
Holding
89
New
18
Increased
21
Reduced
23
Closed
26
Top Buys
| 1 |
RAD
Rite Aid Corporation
RAD
|
$215M |
| 2 |
Netflix
NFLX
|
$179M |
| 3 |
AGN
ALLERGAN INC
AGN
|
$150M |
| 4 |
Martin Marietta Materials
MLM
|
$132M |
| 5 |
Vulcan Materials
VMC
|
$122M |
Top Sells
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
$439M |
| 2 |
Bristol-Myers Squibb
BMY
|
$401M |
| 3 |
ENDP
Endo International plc
ENDP
|
$155M |
| 4 |
Workday
WDAY
|
$122M |
| 5 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
$119M |
Sector Composition
| 1 | Healthcare | 37.84% |
| 2 | Communication Services | 11.85% |
| 3 | Materials | 8.94% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Technology | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OCR
51
DELISTED
OMNICARE INC
OCR
| $17.9M | 0.36% |
269,298
+4,330
| +2% | +$288K |
|
|
IPXL
52
DELISTED
Impax Laboratories, Inc.
IPXL
| $16M | 0.32% |
+534,228
| New | +$16M |
|
53
Bruker
BRKR
$5.16B
| $15M | 0.3% |
616,620
-94,432
| -13% | -$2.29M |
|
|
ALDR
54
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $14.8M | 0.3% |
+738,027
| New | +$14.8M |
|
|
RPRX
55
DELISTED
Repros Therapeutics Inc.
RPRX
| $14.7M | 0.29% |
850,942
-263,520
| -24% | -$4.56M |
|
|
MDCO
56
DELISTED
Medicines Co
MDCO
| $13.9M | 0.28% |
+476,934
| New | +$13.9M |
|
|
AEGR
57
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $10.8M | 0.22% |
+335,921
| New | +$10.8M |
|
|
ARAV
58
DELISTED
Aravive, Inc. Common Stock
ARAV
| $10.6M | 0.21% |
+377,431
| New | +$10.6M |
|
|
RVNC
59
DELISTED
Revance Therapeutics, Inc.
RVNC
| $8.02M | 0.16% |
235,862
-85,041
| -27% | -$2.89M |
|
60
Viatris
VTRS
$12.3B
| $7.71M | 0.15% |
+149,532
| New | +$7.71M |
|
|
EIGR
61
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $6.37M | 0.13% |
397,516
+12,406
| +3% | +$199K |
|
|
RCPT
62
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $3.08M | 0.06% |
+72,283
| New | +$3.08M |
|
63
TherapeuticsMD
TXMD
$12.8M
| – | – |
-2,415,733
| Closed | -$15.2M |
|
|
BLUE
64
DELISTED
bluebird bio
BLUE
| – | – |
-291,031
| Closed | -$6.62M |
|
|
65
Bristol-Myers Squibb
BMY
$96B
| – | – |
-7,722,083
| Closed | -$401M |
|
66
Cigna
CI
$80.3B
| – | – |
-169,613
| Closed | -$14.2M |
|
67
Salesforce
CRM
$245B
| – | – |
-949,774
| Closed | -$54.2M |
|
68
Cemex
CX
$13.2B
| – | – |
-448,556
| Closed | -$5.67M |
|
|
69
iShares MSCI Emerging Markets ETF
EEM
$19B
| – | – |
-10,702,700
| Closed | -$439M |
|
70
Expedia Group
EXPE
$26.6B
| – | – |
-484,412
| Closed | -$35.1M |
|
71
Liberty Global Class C
LBTYK
$4.07B
| – | – |
-1,749,276
| Closed | -$71.2M |
|
72
MacroGenics
MGNX
$112M
| – | – |
-209,212
| Closed | -$5.82M |
|
73
Myriad Genetics
MYGN
$593M
| – | – |
-40,491
| Closed | -$1.38M |
|
74
Pfizer
PFE
$141B
| – | – |
-1,206,879
| Closed | -$38.8M |
|
75
Prothena Corp
PRTA
$441M
| – | – |
-541,983
| Closed | -$20.8M |
|